|
With this week being Coeliac Awareness week, pharmacist Babir Malik created signposting guide for newly diagnosed coeliacs |
|
We’ve repeatedly been told that revalidation is just around the corner, writes Dr Livingstone, but quite frankly the false promises are driving me round the bend |
|
With his local surgeries having gone live with EPS release two last month, contractor Ravi Patel couldn’t help feel a bit disappointed after all the hype |
|
From contract woes to commissioning strife, there’s plenty of issues pharmacists would like answers on. James Bloodworth puts your questions to PSNC chief executive Sue Sharpe |
|
Does being open 60, 80, 100 hours a week or providing 400 MURs a year equate to being at the heart of your community ask Gary Paragpuri |
|
if the answer for pharmacies is service provision, Xrayser ponders what use they are in a surgery dispensary |
|
If the nhs were a private company then it would have folded a long time ago, writes John D'Arcy |
|
CPD editor Chris Chapman discusses approaching patients about their weight and asks whether pharmacists should be charging for services |
|
In the aftermath of two large trials casting serious doubt on pharmacist's role in protecting patients, Peter Dawson welcomed last week’s Lancet riding to the profession's rescue |
|
As Alliance Healthcare and Alliance Boots staff get set for an 894-mile charity cycle ride, team member Adrian Hannell tells C+D what’s getting him motivated |
|
If we are to highlight best practice successfully, then members of the UK medicines supply chain must work together, writes BAPW executive director Martin Sawer |
|
Just in case you thought power-mad GPs' new commissioning powers filled them with glee, writes Dr Livingstone, think again |
|
This comment was written by Teva in response to CPD editor Chris Chapman's video blog How can drugs packaging be improved? Firstly, we enjoy your blog and thank you using it to highlight the very... |
|
New fitness to practise legislation fails to look after the interests of pharmacists, argues David Reissner |
|
"If I invested in pharmacy would the shares rocket like Apple or tank like Northern Rock?" Xrayser ponders the sector's value |
